Tariffs On Medicines
- All
- News
- Videos
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Trump's "Medicine" Reply To Tariff Question As Black Monday Fear Looms
Asian stock markets opened in a bloodbath on Monday as US futures pointed to significant losses on Wall Street over US President Donald Trump's punishing tariffs, even as countries sought compromise with the defiant president.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Trump's "Medicine" Reply To Tariff Question As Black Monday Fear Looms
Asian stock markets opened in a bloodbath on Monday as US futures pointed to significant losses on Wall Street over US President Donald Trump's punishing tariffs, even as countries sought compromise with the defiant president.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
